• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    S&P Pharmaceuticals SPDR (NY: XPH )

    46.41 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EDT, Oct 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 46.41
    Bid (Size) 42.31 (1)
    Ask (Size) 48.50 (1)
    Prev. Close 46.41
    Today's Range 46.41 - 46.41
    52wk Range 34.67 - 47.41
    Shares Outstanding 34,002
    Dividend Yield 1.03%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AstraZeneca Shares Fall Despite EPS Beat and Raised Guidance
    AstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu. 
    Via MarketBeat
    Topics ETFs
    Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits
    The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments,... 
    Via Benzinga
    Topics Bankruptcy Lawsuit
    Exposures Financial Legal

    Performance

    YTD
    +11.35%
    +11.35%
    1 Month
    +4.62%
    +4.62%
    3 Month
    +7.36%
    +7.36%
    6 Month
    +15.08%
    +15.08%
    1 Year
    +29.53%
    +29.53%

    More News

    Read More
    A Look At Pharma ETFs Post Q1 Earnings
    Via Talk Markets
    Topics ETFs
    Organon Beats On Q1, Women's Health Leads the Charge
    Via Benzinga
    A Look At Pharma ETFs After Q4 Earnings
    Via Talk Markets
    Topics ETFs
    3 Pharmaceutical ETFs That Could Be Due For A Rebound
    Via Benzinga
    How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
    Via MarketBeat
    Topics Economy
    Exposures Interest Rates
    Pharma ETFs in Focus Post Q2 Earnings
    Via Talk Markets
    Topics ETFs
    Pharma ETFs Gain Post Q1 Earnings
    Via Talk Markets
    A Look At Pharma ETFs Post Q4 Earnings
    Via Talk Markets
    Pharma ETFs In Focus Post Q3 Earnings
    Via Talk Markets
    Large Cap Biopharma- Well Positioned For Choppy Markets
    Via Talk Markets
    3 Pharma Stocks Yielding Over 3%
    Via Talk Markets
    7 Pharmaceutical Stocks That Could Make You Rich
    Via InvestorPlace
    The Bear Market Is Already Here – But Not For Dividend Investors
    Via Talk Markets
    Wave of Solid Q3 Earnings Push Pharma ETFs Higher
    Via Talk Markets
    The Cost Of Saving The Economy: $1.7 Billion Per Hour Every Hour
    Via Talk Markets
    Topics Bonds Economy
    Exposures Debt Markets Interest Rates
    The 2 Best Pharma Stocks to Buy on Dips
    Via Talk Markets
    Exposures COVID-19
    3 Top Pharma Stocks to Buy This Month
    Via Talk Markets
    Pharma ETFs in Focus Post Q1 Earnings
    Via Talk Markets
    3 Pharmaceutical ETFs That Could Be Due For A Rebound
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.